J. Mansfield

发表

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

Simon C. Potter, P. Donnelly, C. Spencer, 2007, Nature.

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

Judy H. Cho, P. Deloukas, J. Marchini, 2008, Nature Genetics.

Genome-wide association study of copy number variation in 16,000 cases of eight common diseases and 3,000 shared controls

Jake K. Byrnes, Tomas W. Fitzgerald, P. Donnelly, 2010, Nature.

Genome-wide association study of copy number variation in 16,000 cases of eight common diseases and 3,000 shared controls

Jake K. Byrnes, Tomas W. Fitzgerald, Renwick, 2010 .

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

David C. Wilson, Judy H. Cho, C. Gieger, 2012, Nature.

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

Simon C. Potter, David M. Evans, P. Donnelly, 2007, Nature Genetics.

Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease

David C. Wilson, J. Barrett, M. Tremelling, 2016, Nature Genetics.

Human SNP Links Differential Outcomes in Inflammatory and Infectious Disease to a FOXO3-Regulated Pathway

Tariq Ahmad, Alison Simmons, David C. Wilson, 2013, Cell.

IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes

David C. Wilson, Judy H. Cho, C. Gieger, 2018, Nature Communications.

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Judy H. Cho, John P. Ferguson, G. Wainrib, 2019, Scientific Reports.

Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region

P. Donnelly, C. Spencer, C. Freeman, 2010 .

Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study

Tariq Ahmad, Judy H Cho, Vibeke Andersen, 2016, The Lancet.

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

Tariq Ahmad, Albert Cohen, Judy H Cho, 2010, Nature Genetics.

αEβ7 Integrin Identifies Subsets of Pro-Inflammatory Colonic CD4+ T Lymphocytes in Ulcerative Colitis.

J. Mansfield, J. Egen, A. Hayday, 2016, Journal of Crohn's & colitis.

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

Tariq Ahmad, Katherine I. Morley, Vibeke Andersen, 2011, Nature Genetics.

Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility

Alastair Forbes, Lon Cardon, Christopher G Mathew, 2007, Nature Genetics.

Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease

Tariq Ahmad, David C Wilson, David C. Wilson, 2017, Nature Genetics.

OP011 Etrolizumab treatment leads to early improvement in symptoms and inflammatory biomarkers in anti-TNF-refractory patients in the open-label induction cohort of the phase 3 HICKORY study.

R. Maciuca, J. Mansfield, D. Rubin, 2017, Journal of Crohn's & colitis.

Etrolizumab Treatment Leads to Early Improvement in Symptoms and Inflammatory Biomarkers in Anti-TNF-refractory Patients in the Open-Label Induction Cohort of the Phase 3 Hickory Study

R. Maciuca, J. Mansfield, D. Rubin, 2017 .

Role of Polymorphisms in the Interleukin-10 Gene in Determining Disease Susceptibility and Phenotype in Inflamatory Bowel Disease

J. Mansfield, M. Hudson, G. Aithal, 2001, Digestive Diseases and Sciences.

Can faecal calprotectin predict relapse in inflammatory bowel disease: a mini review

J. Mansfield, T. S. Chew, J. Mansfield, 2016, Frontline Gastroenterology.

A double‐blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis

J. Mansfield, P. Cann, C. Holdsworth, 2002, Alimentary pharmacology & therapeutics.

Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial

J. Mansfield, S. Travis, S. Sebastian, 2016, The lancet. Gastroenterology & hepatology.

Information for patients about inflammatory bowel disease.

J. Mansfield, M. Bramble, A. R. Tanner, 1997, Journal of the Royal College of Physicians of London.

Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn’s disease

J. Mansfield, R. Francis, C. Todhunter, 2005, Gut.

Genome-wide association study implicates immune activation of multiple interin genes in inflammatory bowel disease

J. Barrett, M. Tremelling, M. Parkes, 2016 .

Genome-wide association study implicates immune activation of 1 multiple integrin genes in inflammatory bowel disease 2

J. Barrett, M. Tremelling, M. Parkes, 2016 .

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.

J. Barrett, M. Tremelling, M. Parkes, 2019, Gastroenterology.

Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population

S. Fisher, A. Forbes, C. Lewis, 2007, International Journal of Colorectal Disease.

Genetic Variation at the Chromosome 16 Chemokine Gene Cluster: Development of a Strategy for Association Studies in Complex Disease

S. Fisher, A. Forbes, C. Lewis, 2003, Annals of human genetics.

J. Mansfield, 2003, Gut.

Mutation, selection, and evolution of the Crohn disease susceptibility gene CARD15

S. Fisher, A. Forbes, Clive M. Onnie, 2006, Human mutation.

Erratum: Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 (Nature Genetics (2011) 43 (246-252))

Judy H. Cho, M. Daly, R. Ophoff, 2011 .

Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist.

J. Mansfield, H. Holden, G. Duff, 1994, Gastroenterology.

Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's disease.

J. Mansfield, C. Holdsworth, M. Giaffer, 1995, Gut.

Combined evidence from three large British Association studies rejects TUCAN/CARD8 as an IBD susceptibility gene.

S. Fisher, A. Forbes, C. Lewis, 2007, Gastroenterology.

Yersinia enterocolitica Infection in a Patient With Hemachromatosis Masquerading as Proximal Colon Cancer With Liver Metastases: Report of a Case

J. Mansfield, J. Varma, J. Crosbie, 2005, Diseases of the colon and rectum.

Regulation and Role of aE Integrin and Gut Homing Integrins in Migration and Retention of Intestinal Lymphocytes during Inflammatory Bowel Disease

J. Mansfield, A. Filby, J. Hackney, 2021 .

Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease

M. Mohiuddin, J. Mansfield, C. Lamb, 2009, The British journal of surgery.

Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility

Noor B. Dawany, Judy H. Cho, H. Ostrer, 2022, Nature Genetics.

Exploring the genetic architecture of inflammatory bowel disease

Loukas Moutsianas, Alison Simmons, Joshua Randall, 2016 .

Genome-wide association study implicates immune activation of 1 multiple integrin genes in inflammatory bowel disease

J. Barrett, M. Tremelling, M. Parkes, 2016 .

Drug advances in inflammatory bowel disease.

J. Mansfield, R. A. Speight, 2013, Clinical medicine.

159 Differentiation Between Etrolizumab (Rhumab Beta7) and Placebo in the Eucalyptus Phase II Randomized Double-Blind Placebo-Controlled Induction Study to Evaluate Efficacy and Safety in Patients With Refractory Moderate-to-Severely Active Ulcerative Colitis

J. Mansfield, P. Rutgeerts, S. Vermeire, 2013 .

Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn’s Disease

M. Parkes, J. Mansfield, A. Hart, 2020, Digestive Diseases and Sciences.

How Important is Onset of Action in Ulcerative Colitis Therapy?

J. Mansfield, S. Masson, D. Nylander, 2012, Drugs.

A double‐blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis

J. Mansfield, J. Green, G. Kerr, 2002, Alimentary pharmacology & therapeutics.

Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis.

Stefan Schreiber, Paul Rutgeerts, Adrian Hayday, 2016, Gastroenterology.

The Importance of Molecular Immune Investigation in Therapeutic Clinical Development for Biomarker Assessment

J. Mansfield, C. Lamb, J. Kirby, 2018, Journal of Crohn's & colitis.

Management of irritable bowel syndrome

J. Mansfield, M. Gunn, A. Cavin, 2003, Postgraduate medical journal.

BEST PRACTICE Management of irritable bowel syndrome

J. Mansfield, M. Gunn, A. Cavin, 2003 .

T Lymphocytes Expressing AlphaE Beta7 Integrin in Ulcerative Colitis: Associations With Cellular Lineage and Phenotype

J. Mansfield, C. Lamb, J. Kirby, 2017, Journal of Crohn's & colitis.

Anti‐tissue transglutaminase antibodies in the follow‐up of adult coeliac disease

C. A. Lamb, J. Mansfield, G. Spickett, 2009, Alimentary pharmacology & therapeutics.

Negligible impact of rare autoimmune-locus coding-region variants on missing heritability

D. MacArthur, J. Todd, J. Barrett, 2013, Nature.

Editorial: aminosalicylates in Crohn's disease—prevalence, risks, costs and time to re‐assess?

J. Mansfield, L. Macdougall, 2018, Alimentary pharmacology & therapeutics.

Sexually transmitted infections manifesting as proctitis

J. Mansfield, C. Lamb, K. Sankar, 2012, Frontline Gastroenterology.

Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.

M. Tremelling, M. Parkes, C. Lees, 2016, Journal of Crohn's & colitis.

A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis

Beryl B. Cummings, Judy H. Cho, M. Rivas, 2015, Nature Communications.

High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

Hailiang Huang, Stephan Ripke, Andre Franke, 2014, Nature Genetics.

Regulation and Role of αE Integrin and Gut Homing Integrins in Migration and Retention of Intestinal Lymphocytes during Inflammatory Bowel Disease

J. Mansfield, A. Filby, J. Hackney, 2021, The Journal of Immunology.

Sequencing of over 100,000 individuals identifies multiple genes and rare variants associated with Crohns disease susceptibility

Noor B. Dawany, Judy H. Cho, H. Ostrer, 2021, medRxiv.

HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants

M. Tremelling, M. Parkes, C. Lees, 2014, Nature Genetics.

A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5.

S. Fisher, A. Forbes, C. Lewis, 2007, Gastroenterology.

Materials for : Host-microbe interactions shape genetic risk for inflammatory bowel disease

Judy H. Cho, C. Gieger, M. Daly, 2012 .

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Judy H. Cho, John P. Ferguson, G. Wainrib, 2019, Scientific Reports.

TNF2, a polymorphism of the tumour necrosis‐α gene promoter, is a component of the celiac disease major histocompatibility complex haplotype

J. Mansfield, D. Kelleher, G. Duff, 1996, European journal of immunology.

Exome Sequencing and Genotyping Identify a Rare Variant in NLRP7 Gene Associated With Ulcerative Colitis

J. Barrett, N. Prescott, J. Sanderson, 2017, bioRxiv.

Pooled Sequencing of 531 Genes in Inflammatory Bowel Disease Identifies an Associated Rare Variant in BTNL2 and Implicates Other Immune Related Genes

J. Barrett, M. Parkes, J. Satsangi, 2015, PLoS Genetics.

Dose escalation randomised study of efmarodocokin alfa in healthy volunteers and patients with ulcerative colitis

J. Mansfield, M. Rothenberg, B. Harder, 2023, Gut.

Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease

M. Rivas, M. Daly, R. Xavier, 2019, JAMA.

AssociationofGeneticVariantsinNUDT15WithThiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease

M. Rivas, M. Daly, R. Xavier, 2019 .

Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease

Alastair Forbes, Carlo Berzuini, Lon Cardon, 2008, Nature Genetics.

αEβ7 Integrin Identifies Subsets of Pro-Inflammatory Colonic CD4+ T Lymphocytes in Ulcerative Colitis

J. Mansfield, J. Egen, A. Hayday, 2016, Journal of Crohn's & colitis.

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial

J. Mansfield, P. Rutgeerts, S. Vermeire, 2014, The Lancet.

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.

M. Parkes, C. Lees, J. Mansfield, 2019, The lancet. Gastroenterology & hepatology.

Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship.

P. Deloukas, D. Strachan, S. Hunt, 2009, Gastroenterology.

Independent and population-specific association of risk variants at the IRGM locus with Crohn's disease

Yusuke Nakamura, Alastair Forbes, Barbara E. Stranger, 2010, Human molecular genetics.

Quantitative assessment of overall inflammatory bowel disease activity using labelled leucocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods.

J. Mansfield, W. Tindale, C. Holdsworth, 1995, Gut.

Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease.

Christopher G Mathew, Jack Satsangi, Natalie J Prescott, 2010, Human molecular genetics.

IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease

P. Deloukas, L. Cardon, F. Bredin, 2007, Gastroenterology.

CLINICAL-ALIMENTARY TRACT IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease

P. Deloukas, L. Cardon, F. Bredin, 2007 .

Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and Crohn disease in multiple populations from northeast England.

J. Mansfield, P. Donaldson, M. Hudson, 2001, Scandinavian journal of gastroenterology.

Association of DLG5 R30Q variant with inflammatory bowel disease

M. Daly, J. Rioux, S. Fisher, 2005, European Journal of Human Genetics.

Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease.

S. Fisher, A. Forbes, C. Lewis, 2003, American journal of human genetics.

The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.

Alastair Forbes, Christopher G Mathew, Jochen Hampe, 2002, Gastroenterology.

Direct or indirect association in a complex disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn disease

M. Daly, J. Rioux, S. Fisher, 2006, Human mutation.

Genetic Association Analysis Reveals Differences in the Contribution of NOD2 Variants to the Clinical Phenotypes of Orofacial Granulomatosis

N. Prescott, J. Sanderson, C. Mathew, 2016, Inflammatory bowel diseases.

A prospective evaluation of cytology from biliary strictures.

J. Mansfield, V. Wadehra, S. Griffin, 1997, Gut.

Copy number variation of scavenger-receptor cysteine-rich domains within DMBT1 and Crohn's disease

E. Nimmo, J. Satsangi, N. Prescott, 2016, European Journal of Human Genetics.

Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long‐term extension data from a Phase 3 study

J. Mansfield, Fraser Cummings, T. Molnár, 2016, Alimentary pharmacology & therapeutics.

Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease

J. Mansfield, C. Lamb, John C. Mansfield, 2010, Frontline Gastroenterology.

How good is zoom endoscopy for assessment of villous atrophy in coeliac disease?

J. Mansfield, Y. Yiannakou, D. Wooff, 2005, Endoscopy.

Review article: smoking cessation as primary therapy to modify the course of Crohn's disease

J. Mansfield, G. Johnson, J. Cosnes, 2005, Alimentary pharmacology & therapeutics.

The prevention and management of Crohn’s disease postoperative recurrence: results from the Y-ECCO/ClinCom 2019 Survey

J. Mansfield, J. Gisbert, M. Ferrante, 2020, European journal of gastroenterology & hepatology.

A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis

J. Mansfield, P. Rutgeerts, J. Egen, 2012, Gut.

Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment

J. Mansfield, G. Aithal, G. Aithal, 2001, Alimentary pharmacology & therapeutics.

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.

Teck Kiang Tan, J. Mansfield, Fraser Cummings, 2021, The lancet. Gastroenterology & hepatology.

Combined percutaneous and endoscopic procedures for bile duct obstruction: simultaneous and delayed techniques compared.

J. Mansfield, D. Richardson, J. Wayman, 2003, Hepato-gastroenterology.

Percutaneous endoscopic trigonoplasty: a minimally invasive approach to correct vesicoureteral reflux.

J. Mansfield, P. Cartwright, B. Hamilton, 1996, The Journal of urology.

Management of Crohn's disease

J. Mansfield, C. Lamb, S. Needham, 2010, Gut.

The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn’s Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation

Darren L. Smith, M. Tremelling, M. Parkes, 2020, Journal of Crohn's & colitis.

HLA-DQA1*05 is associated with the development of antibodies to anti-TNF therapy

J. Barrett, M. Parkes, C. Lees, 2018, bioRxiv.

Editorial: how effective is vedolizumab in the ‘real world’?

J. Mansfield, R. A. Speight, 2017, Alimentary pharmacology & therapeutics.

AlphaE Integrin Expression Is Increased in the Ileum Relative to the Colon and Unaffected by Inflammation

J. Mansfield, J. Eastham‐Anderson, C. Lamb, 2018, Journal of Crohn's & colitis.

A randomized, double‐blind, placebo‐controlled trial of lenalidomide in the treatment of moderately severe active Crohn’s disease

A. Forbes, J. Mansfield, J. Zeldis, 2007, Alimentary pharmacology & therapeutics.

disease . acid diet in treatment of active Crohn ' s Controlled trial of oligopeptide versus amino

J. Mansfield, C. Holdsworth, M. Giaffer, 2006 .

The Impact of NOD2 Variants on Fecal Microbiota in Crohn’s Disease and Controls Without Gastrointestinal Disease

Julian Parkhill, Alan W Walker, Miles Parkes, 2018, Inflammatory bowel diseases.

Su1220 Rectal Bleeding Accurately Reflects Level of Mucosal Inflammation in Patients With Ulcerative Colitis

Christopher R. Cabanski, J. Mansfield, P. Rutgeerts, 2015 .

Searching for genotype-phenotype structure: using hierarchical log-linear models in Crohn disease.

Claudio J. Verzilli, John C Whittaker, Sheila A Fisher, 2009, American journal of human genetics.

Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry

Tariq Ahmad, Sarah Edkins, Christopher G Mathew, 2011, Nature Genetics.

Oral Ferric Maltol Does Not Adversely Affect the Intestinal Microbiome of Patients or Mice, but Ferrous Sulphate Does

J. Mansfield, U. Ijaz, C. Lamb, 2021, Nutrients.

PREDICTING 5-AMINOSALICYLATE NEPHROTOXICITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.

J. Barrett, M. Parkes, C. Lees, 2011 .

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants.

P. Donnelly, C. Spencer, A. Silman, 2007, Nature genetics.

High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

Judy H. Cho, C. Gieger, H. Hakonarson, 2015 .

Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A

Simon C. Potter, C. Spencer, A. Silman, 2007, Nature.

Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region

Simon C. Potter, P. Donnelly, C. Spencer, 2009, Nature Genetics.

Genome-Wide Association Studies Herald a New Era of Rapid Discoveries in Inflammatory Bowel Disease Research

P. Deloukas, L. Cardon, F. Bredin, 2007 .

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Lisa, Husam, John P. Ferguson, 2023 .

Sequence variation in the CARD15 (NOD2) gene and susceptibity to Crohn's disease

S. Fisher, A. Forbes, J. Sanderson, 2003 .

Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients

M. Parkes, C. Lees, J. Satsangi, 2014, Alimentary Pharmacology and Therapeutics.

Further evidence of an association between the allele 2 of the interleukin-1 receptor antagonist (IL-1RA) gene (IL-1RN) polymorphism and ulcerative colitis (UC)*

N. Camp, J. Mansfield, A. Lobo, 1998 .

Copy number variation of scavenger-receptor cysteine-rich domains within DMBT1 and Crohn's disease

Eld, E. Nimmo, J. Satsangi, 2016, European Journal of Human Genetics.

Genetic variation in the IGSF6 gene and lack of association with inflammatory bowel disease.

S. Fisher, A. Forbes, C. Lewis, 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

P. Donnelly, C. Spencer, A. Silman, 2007, Nature Genetics.

Adenocarcinoma as a complication of small bowel Crohn's disease.

J. Mansfield, C. Rees, R. Shenderey, 2005, European journal of gastroenterology & hepatology.

Multiple SNPs at the IBD5 locus contribute to the risk of Crohn's disease.

S. Fisher, A. Forbes, Clive M. Onnie, 2005 .

Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis.

J. Mansfield, P. Rutgeerts, S. Vermeire, 2016, Gastroenterology.

Exploring the genetic architecture of inflammatory bowel disease by whole genome sequencing identifies association at ADCY7

Shane A. McCarthy, J. Barrett, M. Tremelling, 2016, Nature Genetics.